Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
???displayArticle.abstract???
Abnormal metabolism and sustained proliferation are hallmarks of cancer. Pyruvate kinase M2 (PKM2) is a metabolic enzyme that plays important roles in both processes. Recently, PKM2 was shown to have protein kinase activity phosphorylating histone H3 and promoting cancer cell proliferation. However, the mechanism and extent of this protein kinase in cancer cells remain unclear. Here, we report that binding of succinyl-5-aminoimidazole-4-carboxamide-1-ribose-5'-phosphate (SAICAR), a metabolite abundant in proliferating cells, induces PKM2's protein kinase activity in vitro and in cells. Protein microarray experiments revealed that more than 100 human proteins, mostly protein kinases, are phosphorylated by PKM2-SAICAR. In particular, PKM2-SAICAR phosphorylates and activates Erk1/2, which in turn sensitizes PKM2 for SAICAR binding through phosphorylation. Additionally, PKM2-SAICAR was necessary to induce sustained Erk1/2 activation and mitogen-induced cell proliferation. Thus, the ligand-induced protein kinase activity from PKM2 is a mechanism that directly couples cell proliferation with intracellular metabolic status.
Anastasiou,
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis.
2012,
Pubmed Bartek,
Checking on DNA damage in S phase.
2004,
Pubmed Carpenter,
Receptors for epidermal growth factor and other polypeptide mitogens.
1987,
Pubmed Chang,
Mammalian MAP kinase signalling cascades.
2001,
Pubmed Chen,
Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2.
2011,
Pubmed Christofk,
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth.
2008,
Pubmed Chung,
Glycolytic network restructuring integral to the energetics of embryonic stem cell cardiac differentiation.
2010,
Pubmed Crews,
Extracellular signals and reversible protein phosphorylation: what to Mek of it all.
1993,
Pubmed Edelhoch,
Spectroscopic determination of tryptophan and tyrosine in proteins.
1967,
Pubmed Gao,
Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase.
2012,
Pubmed Gupta,
Human pyruvate kinase M2: a multifunctional protein.
2010,
Pubmed Hake,
Histone H3 variants and their potential role in indexing mammalian genomes: the "H3 barcode hypothesis".
2006,
Pubmed Hanahan,
Hallmarks of cancer: the next generation.
2011,
Pubmed Hanks,
The protein kinase family: conserved features and deduced phylogeny of the catalytic domains.
1988,
Pubmed Haystead,
Ordered phosphorylation of p42mapk by MAP kinase kinase.
1992,
Pubmed Jeyasingham,
Evaluation of phosphoenolpyruvate as a phosphoryl group donor for phosphoproteins in skeletal muscle.
1998,
Pubmed Jiang,
PKM2 regulates chromosome segregation and mitosis progression of tumor cells.
2014,
Pubmed Keller,
SAICAR stimulates pyruvate kinase isoform M2 and promotes cancer cell survival in glucose-limited conditions.
2012,
Pubmed Khandelwal,
Phosphoenolpyruvate-dependent protein kinase activity in rat skeletal muscle.
1983,
Pubmed Kim,
Histone variant H3.3 stimulates HSP70 transcription through cooperation with HP1γ.
2011,
Pubmed Koppenol,
Otto Warburg's contributions to current concepts of cancer metabolism.
2011,
Pubmed Lee,
Pyruvate kinase isozyme type M2 (PKM2) interacts and cooperates with Oct-4 in regulating transcription.
2008,
Pubmed Luo,
Emerging roles of PKM2 in cell metabolism and cancer progression.
2012,
Pubmed Luo,
Pyruvate kinase M2 is a PHD3-stimulated coactivator for hypoxia-inducible factor 1.
2011,
Pubmed Mazurek,
Pyruvate kinase type M2: a crossroad in the tumor metabolome.
2002,
Pubmed Mazurek,
Pyruvate kinase type M2: a key regulator of the metabolic budget system in tumor cells.
2011,
Pubmed McKnight,
Please keep me 2uned to PKM2.
2014,
Pubmed Mitrophanov,
Positive feedback in cellular control systems.
2008,
Pubmed Nilsson,
Cell cycle regulation by the Cdc25 phosphatase family.
2000,
Pubmed Pearson,
Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions.
2001,
Pubmed Postma,
Phosphoenolpyruvate:carbohydrate phosphotransferase systems of bacteria.
1993,
Pubmed Roskoski,
ERK1/2 MAP kinases: structure, function, and regulation.
2012,
Pubmed Sugden,
Monophosphothreonyl extracellular signal-regulated kinases 1 and 2 (ERK1/2) are formed endogenously in intact cardiac myocytes and are enzymically active.
2011,
Pubmed Vander Heiden,
Exploiting tumor metabolism: challenges for clinical translation.
2013,
Pubmed Vander Heiden,
Understanding the Warburg effect: the metabolic requirements of cell proliferation.
2009,
Pubmed Yang,
Nuclear PKM2 regulates β-catenin transactivation upon EGFR activation.
2011,
Pubmed Yang,
PKM2 phosphorylates histone H3 and promotes gene transcription and tumorigenesis.
2012,
Pubmed Yang,
ERK1/2-dependent phosphorylation and nuclear translocation of PKM2 promotes the Warburg effect.
2012,
Pubmed
